Status:
COMPLETED
Feasibility of a Novel, Theory Based Physical Activity Intervention Among Adult Cancer Survivors
Lead Sponsor:
University of Illinois at Urbana-Champaign
Conditions:
Cancer Survivors
Exercise
Eligibility:
All Genders
30-75 years
Phase:
NA
Brief Summary
As the number of cancer survivors grows and expected survival time increases, the health behaviors of this population are gaining significant attention from the research and public health community. A...
Eligibility Criteria
Inclusion
- 30-75 years of age at baseline
- Cancer diagnosis during adulthood (no childhood cancers)
- Low-active (≤ 2 days of 30 minutes of structured exercise/week)
- At least 1 month since last cancer treatment (surgery, chemotherapy and/or radiation)
- No reservations from a doctor/physician/oncologist to engage in physical activity
- Not currently undergoing cancer-related treatment
- No active cancer diagnosis
- Willingness to participate in a 12-week home exercise program
- Willingness to be randomized to either the 12-week home exercise or a 12 week education group
- Access to a laptop/ phone with Zoom web-conferencing software
- An active email address to receive and sign the electronic informed consent
- Willingness to complete study questionnaires before and after the 12-week program, and 3 months after the program
- Fluency in English
Exclusion
- Below 30 or above 75 of age at baseline
- Childhood cancer diagnosis only
- High active (\> 2 days of 30 minutes of structured exercise/week)
- Cancer treatment within the last month or currently undergoing treatment
- Advised to refrain from physical activity by a doctor/physician/oncologist
- Active cancer diagnosis
- Not willing to participate in a 12-week home exercise group and/or complete study assessments
- Not willing to be randomized into one of the two study groups
- No access to a laptop/phone with Zoom software
- No access to active email
- Not fluent in English
Key Trial Info
Start Date :
October 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04498130
Start Date
October 2 2021
End Date
December 31 2022
Last Update
January 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Urbana-Champaign
Urbana, Illinois, United States, 61801